Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer — John P A Ioannidis (2003) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer
Shared by
John P A Ioannidis
Stanford University
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer
Article
2003
en
Authors
+1 more
John P A Ioannidis
Stanford University
AP
Anastasia Polycarpou
CN
Christos Ntais
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2011
A Combined Epigenetic Therapy Equals the Efficacy of Conventional Chemotherapy in Refractory Advanced Non–Small Cell Lung Cancer
Manuel Rodríguez‐Paredes
,
Manel Esteller
Article
1997
163 Second line treatment of advanced non-small-cell lung cancer after cisplatin-based chemotherapy with paclitaxel and gemcitabine
E. Papadakis
,
C. Kourousis
,
Stylianos Kakolyris
,
N. Androulakis
,
Meletios A Dimopoulos
,
S. Tzannes
,
Α. Kotsakis
,
N. Vardakis
,
K. Kalbakis
,
N. Meramveliotakis
,
Dora Hatzidaki
,
V. Georgoulias
Article
2018
Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
Anna Tsiara
,
Michalis Liontos
,
Μαρία Καπαρέλου
,
Roubini Zakopoulou
,
Aristotelis Bamias
,
Meletios A Dimopoulos
Article
2018
Treating ALK-positive non-small cell lung cancer
Dimitrios C. Ziogas
,
Anna Tsiara
,
Georgios Tsironis
,
Maria Lykka
,
Michalis Liontos
,
Aristotelis Bamias
,
Meletios A Dimopoulos
Article
2017
Gefitinib: an “orphan” drug for non-small cell lung cancer
Dimitrios C. Ziogas
,
Michalis Liontos
,
Anastasios Kyriazoglou
,
Georgios Tsironis
,
Aristotelis Bamias
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.